Intermittent fasting comparable to traditional diets for weight loss

May also offer other health benefits, but longer trials are needed to confirm this Intermittent fasting diets appear to have similar benefits to traditional calorie-restricted diets for weight loss, suggests an analysis of trial evidence published by The BMJ today. Alternate day fasting also demonstrates greater benefits compared with both calorie restriction ...

2025-06-19T09:39:25+00:0019 June 2025|Press release, The BMJ|

Prolonged use of desogestrel pill linked to small increased brain tumour risk

Although risk much lower than some other progestogens and disappeared one year after stopping treatment Taking the progestogen-only contraceptive pill desogestrel continuously for more than five years is associated with a small increased risk of developing a type of brain tumour called an intracranial meningioma, finds a study from France ...

2025-06-12T10:53:44+00:0012 June 2025|Press release, The BMJ|

Humanising health: conflict, equity, and resilience

Podcasts Analysis Opinion Recordings Meeting report World Health Innovation Summit (WISH) 2024 BMJ Group partnered with the Qatar Foundation to support the World Health Innovation Summit (WISH) 2024, a leading global health event that brings together policymakers, researchers, and healthcare ...

P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease

Findings support use of P2Y12 therapy instead of aspirin for long term prevention Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, with no increased risk of major bleeding, finds a ...

2025-06-06T11:31:20+00:006 June 2025|Press release, The BMJ|

Diabetes drug shows benefits for patients with liver disease

Results support the potential for dapagliflozin to benefit these patients The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical trial from China published by The BMJ today. The results show that treatment with ...

2025-06-06T11:20:55+00:006 June 2025|Press release, The BMJ|

Leading doctors from India and Pakistan appeal for “brave first steps” towards peace

Persistent conflict and threats of a nuclear conflagration are major impediments to development, they argue  As India and Pakistan once again step closer to an open conflict, leading pediatricians and healthcare professionals from across the border have come together to urge both countries to take “brave first steps” towards peace. ...

2025-05-28T15:02:07+00:0028 May 2025|Press release, The BMJ|

New US dementia cases in decline, but continued rise in people living with the condition

Rates highest among black beneficiaries and those living in more deprived neighborhoods New cases of dementia in the United States declined from 2015 to 2021, but the number of people living with the condition continued to rise due to population ageing, with nearly 2.9 million traditional Medicare beneficiaries (around 12%) ...

2025-05-20T11:08:28+00:0020 May 2025|Press release, The BMJ|
Go to Top